Catalog Download Brands Marketing Channels Business Cooperation Contact Us Site Map
中文版
CCPG
Prescription Drugs
Hematology/Oncology
Musculo-skeletal system
Product Finder
Search

Company Name
Search


Keyword
Search
GEFITINIB 250mg Home > Prescription Drugs >Hematology/Oncology> Hematology/Oncology
 
Product No.
C500045
Class No .
E265
Name
TERNIBIN
Ingredients
GEFITINIB
Dosage Form
F.C. Tab.
Dose
250mg
Indications
Indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) mutations.
Indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who received chemotherapy previously.
Dosage and Administration
250 mg QD until disease progression or unacceptable toxicity
Package
10T/PTP, 3PTP/Box
Drug Type
Prescription Drugs
Controlled Drug
No
Area of Production
Taiwan
Health Insurance No.
AC59239100
CCPC CYH
Relatived Products
Pemetrexed 500mg
Pemetrexed 100mg
Imatinib mesylate 100mg